C

CorMedix
D

CRMD

12.530
USD
0.17
(1.38%)
مغلق
حجم التداول
60,004
الربح لكل سهم
1
العائد الربحي
-
P/E
50
حجم السوق
849,842,977
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 7 أشهر
buy
2024-10-03 07:52
CRMD Chart
المزيد
أصول ذات صلة
A
AGEN
-0.28000
(-7.32%)
3.54500 USD
A
AKBA
0.05500
(1.92%)
2.91500 USD
C
CLRB
-0.00170
(-0.68%)
0.24940 USD
D
DVAX
-0.01500
(-0.15%)
9.78000 USD
M
MDGL
4.26
(1.59%)
271.53 USD
R
RDHL
0.00000
(0.00%)
1.84000 USD
R
RMTI
-0.00490
(-0.51%)
0.96010 USD
S
SNDX
0.08500
(0.86%)
9.93500 USD
المزيد
الأخبار المقالات

العنوان: CorMedix

القطاع: Healthcare
الصناعة: Biotechnology
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.